Willebrand International Non-interventional Global Surveillance

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Von Willebrand Disease
Trial Locations (18)

2650

UZA hopital universitaire, Edegem

20122

University of Milan, Milan

60590

Goethe Universitat, Frankfurt

Unknown

Hopital des enfants Reine Fabiola, Antwerp

University Central Hospital, Helsinki

Charité Universitätsmedizin, Berlin

GZRR Gerinnungszentrum Rhein/ Ruhr, Duisburg

Universitatsklinikum, Essen

Medizinische Hochschule Hannover, Hanover

Werlhof-Institut für Hämostaseologie GmbH, Hanover

Universitätsklinikum Schleswig-Holstein, Kiel

Universitatsklinikum, Mainz

Klinikum der Universität, München

"Hemophilia center LAIKO general hospital", Athens

Centro di Riferimento Regionale per Emofilia e Trombosi, Catania

AOUC- Azienda Ospedaliero-Universitaria Carregi, Florence

Oslo University Hospital, Oslo

625 00

University Hospital, Brno

All Listed Sponsors
lead

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

NCT01949220 - Willebrand International Non-interventional Global Surveillance | Biotech Hunter | Biotech Hunter